Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. INDV
INDV logo

INDV

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

INDV News

Indivior Releases Survey Results on Medication Use in Correctional Facilities

5d agoNewsfilter

SUBLOCADE® Reduces Staffing Costs in Prisons

Mar 31 2026Newsfilter

Significant Gaps in MOUD Access Across U.S. Prisons

Mar 17 2026Yahoo Finance

Indivior Announces $450M Convertible Notes Offering

Mar 13 2026seekingalpha

Indivior Prices Upsized $450 Million Convertible Notes Offering

Mar 13 2026NASDAQ.COM

Indivior Plans $400M Convertible Notes Offering Due 2031

Mar 12 2026seekingalpha

Divisadero Exits Entire Position in Stride

Mar 06 2026Fool

Divisadero Exits Entire Position in Stride

Mar 06 2026NASDAQ.COM

Indivior Pharmaceuticals Reports Q4 2025 Earnings Highlights

Feb 27 2026seekingalpha

Indivior Q4 Earnings Exceed Expectations

Feb 26 2026seekingalpha

Kevin Mahn Advises Investors to Focus on Long-Term Growth Amid Market Volatility

Jan 21 2026Benzinga

Healthcare Sector Outperforms S&P 500 with 12.52% Gain and 3.20 Health Score

Jan 14 2026seekingalpha

Indivior Stock Performance Review: Short-Term Decline vs. Long-Term Gains

Jan 10 2026Yahoo Finance

Stonepine Capital Reduces Indivior Stake by 250,000 Shares, Valuation Drops by $2.75 Million

Dec 28 2025NASDAQ.COM

Stonepine Capital Reduces Indivior Stake by $2.75 Million

Dec 28 2025Fool

Indivior PLC Added to S&P SmallCap 600 Index, Enhancing Market Presence

Dec 22 2025PRnewswire